ADOLESCENT

This phase 2 trial is testing whether an experimental drug called HTD1801 can improve liver health in adolescents with primary sclerosing cholangitis (PSC), a rare disease that damages the bile ducts. Participants will receive either HTD1801 or the standard treatment, ursodeoxych…

This trial tests whether adding substance use disorder resources to existing behavioral health services in pediatric primary care clinics can improve care for adolescents with opioid use disorder. The approach includes training, stigma reduction, and brief interventions during re…

This study tests whether a simple program—including an education session for oral surgeons, patient instruction sheets, and blister packs of acetaminophen and ibuprofen—can reduce opioid prescriptions to adolescents and young adults after tooth extraction. About 38,000 patients a…

This study planned to work with teens to improve a mobile app called Firefly, which uses cognitive behavioral therapy to help with insomnia. The goal was to make the app more engaging for teenagers. However, the study was withdrawn before any participants were enrolled, so no res…